semaglutide bmi 25 Once-weekly 2·4 mg in an Asian population with obesity, defined as ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial Semaglutide | Personalized Weight Loss

It is a gentle way to slow down, check in with your body, and start building awareness in your day-to-day life

Useful for dehydration from illness, travel, intense exercise, or simply not drinking enough water

Many patients remain at lower doses for longer periods if they are experiencing adequate appetite control and weight-loss progress

The effect of three-month semaglutide treatment on serum TSH and thyroid hormones in individuals with obesity

These results highlight the importance of adherence in achieving optimal weight loss outcomes and emphasize the need for strategies to support patients throughout their treatment journey in the obesity diabetes cohort, including further weight reduction

Facial fat loss from weight reduction differs from aging